PHK
OLMA icon

Point72 Hong Kong’s Olema Pharmaceuticals OLMA Stock Holding History

Point72 Hong Kong’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-457
Closed -$1K – 1205
2022
Q3 		$1K Buy
+457
New +$1.94K ﹤0.01% 1863

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Hong Kong's OLMA Position: Q4 2022 in Review

Point72 Hong Kong sold out of Olema Pharmaceuticals (OLMA) in Q4 2022, closing a stake of 457 shares — an estimated $1K sold.

Point72 Hong Kong first reported a position in OLMA in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 67 funds tracked by Wall St. Rank hold OLMA as of Q4 2022.

  • Point72 Hong Kong reported no remaining Olema Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 457 Olema Pharmaceuticals shares in Q4 2022, an estimated $1K.
  • Point72 Hong Kong first reported a position in Olema Pharmaceuticals in Q3 2022 and held it in 1 quarter.
  • Point72 Hong Kong's Olema Pharmaceuticals position peaked at $1K in Q3 2022.
  • 67 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.